Clinical Trial Update: Observational Study Protocol: LIVER-R

View source ↗

Summary

An observational study protocol called LIVER-R sponsored by AstraZeneca focusing on hepatobiliary cancers, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Hepatocellular Carcinoma

Snippet

Sponsor: AstraZeneca | Conditions: Hepatobiliary Cancers | Status: RECRUITING